These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11898580)

  • 61. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
    Liao JK
    Circulation; 2007 Mar; 115(12):1615-21. PubMed ID: 17389280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of antithrombotics in secondary stroke prevention.
    Lazzaro MA; Malhotra K; Mohammad YM
    Semin Neurol; 2010 Nov; 30(5):492-500. PubMed ID: 21207341
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ischemic stroke prevention: an update on antiplatelet therapy.
    Neill KK; Luer MS
    Neurol Res; 2002 Jun; 24(4):381-8. PubMed ID: 12069286
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stroke prevention. MATCHing therapy to the patient with TIA.
    Weir NU; Demchuk AM; Buchan AM; Hill MD
    Postgrad Med; 2005 Jan; 117(1):26-30. PubMed ID: 15672888
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antiplatelet agents for stroke prevention following transient ischemic attack.
    Weinberger J
    South Med J; 2008 Jan; 101(1):70-8. PubMed ID: 18176296
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
    Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
    Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A benefit-risk assessment of agents used in the secondary prevention of stroke.
    MacWalter RS; Shirley CP
    Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
    Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
    Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.
    Eikelboom JW; Hart RG
    Am J Hematol; 2012 May; 87 Suppl 1():S100-7. PubMed ID: 22389052
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
    Aw D; Sharma JC
    Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
    [TBL] [Abstract][Full Text] [Related]  

  • 73. close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.
    Mas JL; Derumeaux G; Amarenco P; Arquizan C; Aubry P; Barthelet M; Bertrand B; Brochet E; Cabanes L; Donal E; Dubois-Randé JL; Durand-Zaleski I; Ernande L; Finet G; Fraisse A; Giroud M; Guérin P; Habib G; Juliard JM; Leys D; Lièvre M; Lusson JR; Marcon F; Michel P; Moulin T; Mounier-Vehier F; Pierard L; Piot C; Rey C; Rodier G; Roudaut R; Schleich JM; Teiger E; Turc G; Vuillier F; Weimar C; Woimant F; Chatellier G;
    Int J Stroke; 2016 Aug; 11(6):724-32. PubMed ID: 27056964
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antithrombotic drug treatment of pediatric patients with ischemic stroke.
    Nowak-Göttl U; Sträeter R; Sébire G; Kirkham F
    Paediatr Drugs; 2003; 5(3):167-75. PubMed ID: 12608881
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature.
    Dutta M; Hanna E; Das P; Steinhubl SR
    Cerebrovasc Dis; 2006; 22(5-6):331-9. PubMed ID: 16888371
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation.
    Damani RH; Suarez JI
    South Med J; 2016 Nov; 109(11):721-729. PubMed ID: 27812719
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of antiplatelet agents for prevention of ischemic stroke.
    Callison RC; Adams HP
    Neurol Clin; 2008 Nov; 26(4):1047-77, ix. PubMed ID: 19026902
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transient ischemic attack (TIA): the initial diagnostic and therapeutic dilemma.
    Panagos PD
    Am J Emerg Med; 2012 Jun; 30(5):794-9. PubMed ID: 21570239
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antithrombotic drugs for carotid artery dissection.
    Lyrer P; Engelter S
    Cochrane Database Syst Rev; 2000; (4):CD000255. PubMed ID: 11034680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.